Sanguine Genetics Profile
Key Indicators
- Authorised Capital ₹ 8.35 Cr
- Paid Up Capital ₹ 3.34 M
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 24.59%
- Profit Growth 112.72%
- Ebitda 262.11%
- Net Worth 151.51%
- Total Assets -1.21%
About Sanguine Genetics
Sanguine Genetics Private Limited (SGPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 July 2005 and has a history of 19 years and six months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Corporate was formerly known as Sanguine Genetics Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.35 Cr and a paid-up capital of Rs 3.34 M, as per Ministry of Corporate Affairs (MCA) records.
Shobana Prakash and Kabali Baskaran serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01403TN2005PTC056955
-
Company No.
056955
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jul 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sanguine Genetics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shobana Prakash
|
Director | 04-May-2015 | Current |
|
Kabali Baskaran
|
Director | 09-Mar-2021 | Current |
Financial Performance of Sanguine Genetics.
Sanguine Genetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.59% increase. The company also saw a substantial improvement in profitability, with a 112.72% increase in profit. The company's net worth Soared by an impressive increase of 151.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Genetics?
In 2023, Sanguine Genetics had a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanguine Genetics?
Sanguine Genetics has a workforce of 11 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.